This is essentially breaking new ground and having a test that can accurately predict something well into the future will be met with skepticism. The more validation and peer reviews done the better. It may seem like repetition but every time another institute/research group validate results, it strengthens the position of the technology and its ability to predict accurate outcomes and validate why it should be the test of choice for all Diabetics.
Ann: PromarkerD clinical assay performance results published, page-6
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
0.020(2.60%) |
Mkt cap ! $103.4M | |||
| Open | High | Low | Value | Volume |
| 77.0¢ | 79.0¢ | 77.0¢ | $98.88K | 126.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15331 | 77.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.0¢ | 7886 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |